Frequency of Homocysteinemia in Ischemic Stroke Patients
DOI:
https://doi.org/10.52206/jsmc.2019.9.2.%25pAbstract
Background: Stroke is a form of cardiovascular disease affecting the blood supply to the brain, resulting in neurologic deficit in the
corresponding area of the body. Epidemiologic studies have identified homocysteinemia as a possible risk factor for
atherosclerosis. It was ranked as the second most common cause of death and the third most common cause of disability in the
world by WHO in 2010.
Objective: To assess the frequency of homocysteinemia in patients of ischemic stroke and determine relationship between
homocysteinemia and other factors like age, sex, hypertension, diabetes and smoking.
Material and Methods: A single centered cross sectional study which included100 patients of ischemic stroke admitted in the
department of Medicine, Benazir Bhutto Hospital Rawalpindi in 2016.
Results: The mean age of patients was 59.06 ±11.501 years and the mean serum homocysteine level of the patients was 15.38 ±
6.93 m mol/dl. There were 35 patients having homocysteinemia with ischemic stroke while in 65 patients homocysteine level was
within normal range. The presence of homocysteinemia was found to be significantly more in non-diabetics (p< 0.02) and
normotensive (p<0.001) patients as compared to diabetic and hypertensive patients respectively. The presence of
homocysteinemia in smokers and non-smokers was not statistically significant (p=0.151).
Conclusion: The frequency of homocysteinemia was 35% in patients of ischemic stroke in our study and was more in nondiabetics
and normotensive patients.
Further large, multi-center trials are required to demonstrate the relationship between homocysteinemia and other diseases.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.



